on NANOBIOTIX (EPA:NANO)
NANOBIOTIX Enhances Supervisory Board with Two Key Additions
NANOBIOTIX has announced the appointment of Dr. Margaret A. Liu and Ms. Anat Naschitz to its Supervisory Board. These nominations aim to bolster the company's capacity for sustainable long-term growth.
Dr. Liu, a global expert in vaccines, gene therapy, and cancer immunotherapy, serves as CEO of PAX Therapeutics. Her extensive experience in academia, pharmaceuticals, and biotechnology is expected to be instrumental for NANOBIOTIX.
Ms. Naschitz, a seasoned life science investor and entrepreneur, is the co-founder of OrbiMed Israel. She brings a wealth of knowledge in capital utilization and biopharma investment, crucial for supporting the company's innovation strategies.
Laurent Levy, CEO and Chairman of NANOBIOTIX, stated that these new board members would be pivotal in advancing the company's nanophysics-based therapies for cancer treatment.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NANOBIOTIX news